On-body Injectors Market Size To Reach $12.7 Billion By 2030

On-body Injectors Market Growth & Trends

The global on-body injectors market size is expected to reach USD 12.7 billion by 2030, registering a CAGR of 14.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The on-body injectors increase patient adherence to medication by offering easy-to-use, less pain and enabling extended drug administration without frequent hospital visits. These advantages of on-body injectors are significantly increasing their popularity. Moreover, regions such as Asia Pacific, with developing healthcare infrastructure and rising adoption of advanced medical devices, offer huge opportunities for market growth over the forecast period.

The increasing concerns over needle stick injuries and the need to increase the safety for both patients and healthcare professionals by eliminating risks associated with needle insertion, drug preparation, and covering & disposing of needles, coupled with the increasing prevalence of chronic diseases such as cancer are some of the factors expected to drive the market growth over the forecast period.

According to the WHO agency International Agency for Research on Cancer (IARC), around 20 million people were diagnosed with cancer, and around 9.7 million mortalities occurred due to cancer in 2022. Several cancers and other chronic disease treatments require frequent injections of medications over extended periods. On-body injectors offer a convenient and potentially less disruptive alternative for patients to receive these medications compared to traditional hospital visits or self-administered injections, which can significantly increase their demand over the forecast period.

 Request a free sample copy or view report summary: On-body Injectors Market Report

On-body Injectors Market Report Highlights

• Based on the technology, the spring-based segment accounted for the largest revenue share of 40.89% in 2023 owing to their consistent pressure and speed, which ensures precise dosing

• Based on technology, the rotary pump segment is expected to grow at the fastest CAGR of 15.1% during the forecast period owing to the high control offered by them in dispensing medications, minimizing the risk of dosing errors and maximizing therapeutic efficacy

• Based on the application, the diabetes segment accounted for the largest revenue share in 2023 due to the high prevalence of type 2 diabetes, which requires frequent administration

• Based on the application, the autoimmune diseases segment is expected to grow at the fastest CAGR owing to the rising prevalence of chronic autoimmune conditions such as multiple sclerosis, rheumatoid arthritis, and Inflammatory Bowel Diseases (IBD)

• Based on the end use, the homecare segment accounted for the largest revenue share in 2023 owing to the growing preference for self-administration of medications for managing chronic conditions such as diabetes, autoimmune disorders, and cancer in homecare settings

• In 2023, North America dominated with a share of 33.17%, driven by the presence of key market players, an increasing shift toward home care, and better access to advanced on-body injectors 

On-body Injectors Market Segmentation

Grand View Research has segmented the global on-body injectors market based on technology, application, end-use, and region:

On-body Injectors Technology Outlook (Revenue, USD Million, 2018 - 2030­)

• Spring-based

• Motor-driven

• Rotary Pump

• Expanding Battery

• Other

On-body Injectors Application Outlook (Revenue, USD Million, 2018 - 2030)

• Oncology

• Diabetes

• Cardiovascular Disease

• Autoimmune Disease

• Others

On-body Injectors End Use Outlook (Revenue, USD Million, 2018 - 2030)

• Hospitals & Clinics

• Home Care Settings

• Others

On-body Injectors Region Outlook (Revenue, USD Million, 2018 - 2030)

• North America

  • U.S.

  • Canada

  • Mexico

• Europe

  • UK

  • Germany

  • France

  • Italy

  • Spain

  • Denmark

  • Sweden

  • Norway

• Asia Pacific

  • Japan

  • China

  • India

  • Australia

  • South Korea

  • Thailand

• Latin America

  • Brazil

  • Argentina

• Middle East & Africa

  • South Africa

  • Saudi Arabia

  • UAE

  • Kuwait

List of Key Players in the On-body Injectors Market

• West Pharmaceutical Services, Inc.

• BD

• Stevanato Group

• Enable Injections

• Nemera

• Debiotech SA

• AbbVie, Inc.

• Coherus BioSciences, Inc.

• Gerresheimer AG

• E3D Elcam Drug Delivery Devices